omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension
omeprazole
RxCUI: 753562
What the CMS Formulary Data Shows for omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension
Per the CMS 2026 Part D formulary file, omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension (RxNorm concept RXCUI 753562, generic name omeprazole) appears on 6 distinct formulary files spanning 12 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.
Real-world access to omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension depends on utilization management as much as tier placement: 33.3% of covering formularies require prior authorization. 0% require step therapy. 33.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 7,298,218 Part D beneficiaries filled omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension in 2023, with total plan-and-beneficiary spending of $422,372,715 and an average per-beneficiary annual cost of $57.87. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 12
- Coverage rate
- 0.2%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 33.3% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 33.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 7,298,218
- Total spending
- $422,372,715
- Avg per beneficiary
- $57.87
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension
12 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | ELDERPLAN, INC. | T1 | Yes | $0 | NY |
| Mass General Brigham SCO (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | No | $0 | MA |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | ELDERPLAN, INC. | T1 | Yes | $22.70 | NY |
| Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) | ELDERPLAN, INC. | T1 | Yes | $44.80 | NY |
| Elderplan Flex (HMO-POS) | ELDERPLAN, INC. | T5 | Yes | $0 | NY |
| Elderplan Select (HMO-POS I-SNP) | ELDERPLAN, INC. | T5 | Yes | $0 | NY |
| Mass General Brigham Advantage (PPO) | Mass General Brigham Health Plan, Inc. | T5 | No | $0 | MA |
| Elderplan Extra Help (HMO-POS) | ELDERPLAN, INC. | T5 | Yes | $58.80 | NY |
| Mass General Brigham Advantage Secure (HMO-POS) | Mass General Brigham Health Plan, Inc. | T5 | No | $62.00 | MA |
| Mass General Brigham Advantage Premier (PPO) | Mass General Brigham Health Plan, Inc. | T5 | No | $79.70 | MA |
| Mass General Brigham Advantage Signature (PPO) | Mass General Brigham Health Plan, Inc. | T5 | No | $147.20 | MA |
Frequently Asked Questions
Is omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension covered by Medicare Part D?
Yes, omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension is covered by 12 Medicare Part D plans (0.2% of all Part D formularies).
What tier is omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension on Medicare Part D plans?
omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension averages Tier 3 across Part D plans, ranging from Tier 1 to Tier 5.
Does omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension require prior authorization?
33.3% of Part D formularies require prior authorization for omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension. Step therapy: 0%. Quantity limits: 33.3%.
How much does Medicare spend on omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension?
In 2023, total Medicare Part D spending on omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension was $422,372,715, covering 7,298,218 beneficiaries. The average spend per beneficiary was $57.87.
Read our methodology - how this data is sourced, computed, and verified.